About
X-Zell develops a CE-marked multiplex cytopathology platform integrating direct-to-slide cryofixation, multiplex immunostaining, and hybrid microscopy to provide detailed diagnostic analysis from limited cytology samples such as fluids and fine needle aspirations.
Explore X-Zell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.